Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis

Hypertension

Volumn 59, Issue 2 SUPPL. 1, 2012, Pages 421-430

  Manhiani, M Marlina ^a   Duggan, A Daniel ^a   Wilson, Hunter ^a   Brands, Michael W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

blood pressure; diabetes mellitus; glomerular filtration rate; insulin; lithium; sodium excretion

Indexed keywords

ALLOXAN; GLUCOSE; INSULIN; ANTIDIABETIC AGENT; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DIURESIS; DOG; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TUBULE ABSORPTION; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY; SODIUM EXCRETION; URINE VOLUME; ANIMAL; ARTICLE; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; MICTURITION; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE; BLOOD GLUCOSE MONITORING; INSULIN TREATMENT;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DIURESIS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOMERULAR FILTRATION RATE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRA-ARTERIAL; INSULIN; MALE; NATRIURESIS; SODIUM; URINATION;

EID: 84856118935     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.185215     Document Type: Conference Paper

References (44)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752. (Pubitemid 41532612)
2. Lastra G, Dhuper S, Johnson MS, Sowers JR. Salt, aldosterone, and insulin resistance: Impact on the cardiovascular system. Nat Rev Cardiol. 2010;7:577-584.
3. Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: Similarities and differences. J Clin Hypertens (Greenwich). 2011;13:238-243.
4. Bickel CA, Verbalis JG, Knepper MA, Ecelbarger CA. Increased renal Na-K-ATPase, NCC, andβ-ENaC abundance in obese Zucker rats. Am J Physiol Renal Physiol. 2001;281:F639-F648.
5. Miller JH, Bogdonoff MD. Antidiuresis associated with administration of insulin. J Appl Physiol. 1954;6:509-512.
6. + exchange activity in proximal tubules from normotensive and hypertensive rats. Am J Physiol. 1991;260:F695-F703.
7. Kirchner KA. Insulin increases loop segment chloride reabsorption in the euglycemic rat. Am J Physiol. 1988;255:F1206-F1213.
8. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975;55:845-855.
9. Stenvinkel P, Bolinder J, Alvestrand A. Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia. 1992;35:1042-1048.
10. Skott P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck- Nielsen H, Parving HH. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia. 1989;32:694-699. (Pubitemid 19235997)
11. Friedberg CE, van Buren M, Bijlsma JA, Koomans HA. Insulin increases sodium reabsorption in diluting segment in humans: Evidence for indirect mediation through hypokalemia. Kidney Int. 1991;40:251-256.
12. Catena C, Cavarape A, Novello M, Giacchetti G, Sechi LA. Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. Kidney Int. 2003;64:2163-2171. (Pubitemid 37449551)
13. Hwang I-S, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512-516. (Pubitemid 18011228)
14. Song J, Hu X, Riazi S, Tiwari S, Wade JB, Ecelbarger CA. Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats. Am J Physiol Renal Physiol. 2006;290:F1055-F1064. (Pubitemid 43724904)
15. Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension. 1997;29:1014-1019. (Pubitemid 27152474)
16. + channel (ENaC), hormones, and hypertension. J Biol Chem. 2010;285:23527-23531.
17. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: An unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol. 2007;27:44-54. (Pubitemid 46364540)
18. Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart GA, Hildebrandt DA. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs. Hypertension. 1995;25:994-1002.
19. Hall JE, Coleman TG, Mizelle HL, Smith MJJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol. 1990;258:F722-F731. (Pubitemid 20103142)
20. Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs. Am J Hypertens. 1991;4:164-168.
21. Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol. 1991;260:F663-F669.
22. Tsutsu N, Nunoi K, Kodama T, Nomiyama R, Iwase M, Fujishima M. Lack of association between blood pressure and insulin in patients with insulinoma. J Hytertension. 1990;8:479-482. (Pubitemid 20347083)
23. Pontiroli AE, Alberetto M, Pozza G. Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetologia. 1992;35:294-295.
24. Whaley-Connell A, McCullough PA, Sowers JR. The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med. 2011;12:21-29.
25. Manhiani MM, Cormican MT, Brands MW. Chronic sodium-retaining action of insulin in diabetic dogs. Am J Physiol Renal Physiol. 2011;300: F957-F965.
26. Bardgett ME, McCarthy JJ, Stocker SD. Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia. Hypertension. 2010;55:284-290.
27. Landsberg L. Insulin sensitivity in the pathogenesis of hypertension and hypertensive complications. Clin Exp Hypertens. 1996;18:337-346. (Pubitemid 26148652)
28. Herd JA, Barger AC. Simplified technique for chronic catheterization of blood vessels. J Appl Physiol. 1964;19:791-792.
29. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: A tubulo-centric view. J Am Soc Nephrol. 2003;14:530-537. (Pubitemid 36150878)
30. Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics in hyperglycemia: Possible role of tubuloglomerular feedback. Am J Physiol. 1987;252:F65-F71.
31. Bell TD, DiBona GF, Wang Y, Brands MW. Mechanisms for renal blood flow control early in diabetes as revealed by chronic flow measurement and transfer function analysis. J Am Soc Nephrol. 2006;17:2184-2192. (Pubitemid 44141908)
32. Ackermann TF, Boini KM, Volkl H, Bhandaru M, Bareiss PM, Just L, Vallon V, Amann K, Kuhl D, Feng Y, Hammes HP, Lang F. SGK1- sensitive renal tubular glucose reabsorption in diabetes. Am J Physiol Renal Physiol. 2009;296:F859-F866.
33. Saad S, Stevens VA, Wassef L, Poronnik P, Kelly DJ, Gilbert RE, Pollock CA. High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule. Kidney Int. 2005;68:985-997. (Pubitemid 43246415)
34. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoidinducible kinase isoforms. Physiol Rev. 2006;86:1151-1178. (Pubitemid 44521650)
35. Hills CE, Squires PE, Bland R. Serum and glucocorticoid regulated kinase and disturbed renal sodium transport in diabetes. J Endocrinol. 2008;199:343-349.
36. Persson P, Hansell P, Palm F. Tubular reabsorption and diabetes-induced glomerular hyperfiltration. Acta Physiol (Oxf). 2010;200:3-10.
37. Blazer-Yost BL, Esterman MA, Vlahos CJ. Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity. Am J Physiol Cell Physiol. 2003;284:C1645-C1653. (Pubitemid 36583406)
38. Blazer-Yost BL, Liu X, Helman SI. Hormonal regulation of ENaCs: Insulin and aldosterone. Am J Physiol. 1998;274:C1373-C1379.
39. Baquero AF, Gilbertson TA. Insulin activates epithelial sodium channel (ENaC) via phosphoinositide 3-kinase in mammalian taste receptor cells. Am J Physiol Cell Physiol. 2011;300:C860-C871.
40. Hills CE, Bland R, Bennett J, Ronco PM, Squires PE. High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem. 2006;18:337-346. (Pubitemid 44948044)
41. Wang J, Barbry P, Maiyar AC, Rozansky DJ, Bhargava A, Leong M, Firestone GL, Pearce D. SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am J Physiol Renal Physiol. 2001;280:F303-F313.
42. de Paula RB, da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension. 2004;43:41-47. (Pubitemid 38031909)
43. Calhoun DA, White WB. Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension. J Am Soc Hypertens. 2008;2:462-468.
44. Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: Theory and therapy. Hypertension. 2004;43:518-524. (Pubitemid 38282420)